Federated Hermes’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $759K | Buy |
10,656
+611
| +6% | +$41.8K | ﹤0.01% | 1191 |
|
|
2025
Q4 | $594K | Sell |
10,045
-291
| -3% | -$15.8K | ﹤0.01% | 1260 |
|
|
2025
Q3 | $570K | Buy |
10,336
+384
| +4% | +$20K | ﹤0.01% | 1305 |
|
|
2025
Q2 | $429K | Sell |
9,952
-11,187
| -53% | -$432K | ﹤0.01% | 1372 |
|
|
2025
Q1 | $837K | Buy |
21,139
+165
| +0.8% | +$7.3K | ﹤0.01% | 1159 |
|
|
2024
Q4 | $855K | Hold |
20,974
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q3 | $818K | Buy |
20,974
+8
| +0% | +$319 | ﹤0.01% | 1189 |
|
|
2024
Q2 | $916K | Buy |
+20,966
| New | +$1.01M | ﹤0.01% | 1137 |
|
|
2023
Q3 | – | Sell |
-11
| Closed | -$640 | – | 2166 |
|
|
2023
Q2 | $640 | Sell |
11
-4,707
| -100% | -$282K | ﹤0.01% | 2044 |
|
|
2023
Q1 | $337K | Sell |
4,718
-2,709
| -36% | -$215K | ﹤0.01% | 1499 |
|
|
2022
Q4 | $523K | Sell |
7,427
-880
| -11% | -$62K | ﹤0.01% | 1357 |
|
|
2022
Q3 | $504K | Buy |
8,307
+2,085
| +34% | +$140K | ﹤0.01% | 1332 |
|
|
2022
Q2 | $393K | Sell |
6,222
-3,935
| -39% | -$256K | ﹤0.01% | 1418 |
|
|
2022
Q1 | $651K | Sell |
10,157
-2,610
| -20% | -$175K | ﹤0.01% | 1385 |
|
|
2021
Q4 | $916K | Buy |
12,767
+2,505
| +24% | +$191K | ﹤0.01% | 1314 |
|
|
2021
Q3 | $732K | Sell |
10,262
-620
| -6% | -$48.9K | ﹤0.01% | 1390 |
|
|
2021
Q2 | $886K | Sell |
10,882
-6,052
| -36% | -$487K | ﹤0.01% | 1359 |
|
|
2021
Q1 | $1.28M | Buy |
16,934
+1,510
| +10% | +$110K | ﹤0.01% | 1282 |
|
|
2020
Q4 | $1.17M | Sell |
15,424
-11,599
| -43% | -$755K | ﹤0.01% | 1268 |
|
|
2020
Q3 | $1.34M | Sell |
27,023
-12,720
| -32% | -$718K | ﹤0.01% | 1137 |
|
|
2020
Q2 | $2.09M | Buy |
39,743
+27,630
| +228% | +$1.31M | 0.01% | 981 |
|
|
2020
Q1 | $426K | Sell |
12,113
-86,991
| -88% | -$5.08M | ﹤0.01% | 1424 |
|
|
2019
Q4 | $8.66M | Sell |
99,104
-949
| -0.9% | -$83K | 0.02% | 628 |
|
|
2019
Q3 | $8.49M | Sell |
100,053
-43,553
| -30% | -$3.88M | 0.02% | 620 |
|
|
2019
Q2 | $15.1M | Sell |
143,606
-382,111
| -73% | -$38.4M | 0.04% | 435 |
|
|
2019
Q1 | $55.5M | Buy |
525,717
+61,937
| +13% | +$6.22M | 0.14% | 167 |
|
|
2018
Q4 | $38.8M | Sell |
463,780
-182,139
| -28% | -$16.5M | 0.11% | 211 |
|
|
2018
Q3 | $65.8M | Buy |
645,919
+91,792
| +17% | +$8.86M | 0.15% | 152 |
|
|
2018
Q2 | $44.8M | Buy |
554,127
+129,617
| +31% | +$10.3M | 0.13% | 145 |
|
|
2018
Q1 | $31.3M | Buy |
424,510
+8,910
| +2% | +$667K | 0.09% | 186 |
|
|
2017
Q4 | $29.3M | Sell |
415,600
-40,500
| -9% | -$2.92M | 0.08% | 198 |
|
|
2017
Q3 | $28.5M | Sell |
456,100
-130,500
| -22% | -$7.73M | 0.08% | 206 |
|
|
2017
Q2 | $33.7M | Buy |
586,600
+141,100
| +32% | +$8.3M | 0.1% | 179 |
|
|
2017
Q1 | $27.1M | Hold |
445,500
| – | – | 0.08% | 223 |
|
|
2016
Q4 | $24.4M | Buy |
445,500
+61,325
| +16% | +$2.94M | 0.07% | 230 |
|
|
2016
Q3 | $17.7M | Buy |
+384,175
| New | +$16.2M | 0.05% | 288 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Federated Hermes's NGVT Position: Q1 2026 in Review
Federated Hermes increased its Ingevity (NGVT) stake by 6.1% in Q1 2026, buying an estimated $41.8K and bringing the position to 10,656 shares worth $759K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.
Federated Hermes first reported a position in NGVT in Q3 2016 and has held it in 36 quarters since. The position peaked at $65.8M in Q3 2018. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Federated Hermes held 10,656 shares of Ingevity worth $759K as of Q1 2026.
- Federated Hermes bought 611 Ingevity shares in Q1 2026, an estimated $41.8K.
- Ingevity made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1191 holding.
- Federated Hermes first reported a position in Ingevity in Q3 2016 and has held it in 36 quarters since.
- Federated Hermes's Ingevity position peaked at $65.8M in Q3 2018.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.